Stockreport

Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing [Yahoo! Finance]

Pluri Inc.  (PLUR) 
PDF HAIFA, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells [Read more]